Pelthos Therapeutics PTHS
NYSE PTHS
$25.77 -0.89 (-3.34%)
As of: Aug 21, 2026 · 3:59 PM EDT

Pelthos Therapeutics (PTHS) Tax Rate (2025)

Pelthos Therapeutics (PTHS) posted quarterly Tax Rate of 24.21% for Q4 2025, up 769.8% quarter-over-quarter from 2.78% in Q3 2025.

Pelthos Therapeutics (PTHS) Tax Rate (2025) Analysis & Trends

Pelthos Therapeutics' Tax Rate history runs 1 years deep, the most recent figure standing at 24.21% for Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 20.98%
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 15.11%
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 10.91%
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -1.96%
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 24.15%
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 7.49%
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 34.12%
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -16.71%
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Pelthos Therapeutics 91.09 Mn 66.53 Mn 21.23 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 24.21%
Dec 31, 2025 24.21%
Dec 31, 2025 24.21%
Sep 30, 2025 2.78%
Sep 30, 2025 2.78%
Sep 30, 2025 2.78%